Table 4.
Percentage reduction in absolute count absolute residuals after two years in the program
| Platform | CD4 | CD8 |
|---|---|---|
| Single Platform Technology | 6.6% | 10.0% |
| Dual Platform Technology | 19.0% | 21.4% |
Percentage reduction in absolute count absolute residuals after two years in the program
| Platform | CD4 | CD8 |
|---|---|---|
| Single Platform Technology | 6.6% | 10.0% |
| Dual Platform Technology | 19.0% | 21.4% |